Pharmacist-led patient counseling appear to have some benefits
Citation: Okumura LM, Rotta I, Correr CJ. Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review. International journal of clinical pharmacy. 2014 Oct 1;36(5):882-91.
Free to view: No
What is this? The COVID-19 pandemic is placing a strain on healthcare services. Existing research on pharmacist-delivered drug education services might provide useful information for policy makers.
In this systematic review, the authors searched for randomized trials of pharmacist-delivered counseling or education interventions. They restricted their search to articles published in English, Spanish or Portuguese between 1990 and 2013. They included 101 studies, which they judged to be of generally inadequate quality.
What works: The included studies suggest that pharmacist-led interventions produce health improvements in diabetes, asthma, lipid profile, Helicobacter pylori infection, heart conditions, weight loss, pulmonary function improvement, tobacco cessation, depression, schizophrenia, kidney and osteoporosis.
The included studies suggest that clinical pharmacist-led interventions improved quality of life and patients’ satisfaction with service and led to increased physical activity and consumption of nutritive food and smoking cessation.
The included studies suggest that other positive outcomes of pharmacist-led interventions include drug therapy self-monitoring and cost savings related to use of drug therapy.
What doesn’t work: Nothing noted.
What’s uncertain: The relative effects of different types of pharmacist-led interventions (e.g. written or verbal) and the effects for different types of person are uncertain.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.